1 / 7

Xerostomia (Dry Mouth) Therapeutics Market

Xerostomia (Dry Mouth) Therapeutics Market Size, Share, Trends, & Industry Analysis Report, By Product (Artificial Saliva, Dentifrices, Salivary Stimulants, Saliva Substitutes, Drugs, and Salivary Pen); By Distribution Channel; By Regions: Segment Forecast, 2019 - 2026

Sam32
Télécharger la présentation

Xerostomia (Dry Mouth) Therapeutics Market

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Xerostomia (Dry Mouth) Therapeutics Market Market USD 822.1 million by 2026 | CAGR: 3.6%

  2. Xerostomia (Dry Mouth) Therapeutics Market Size Worth USD 822.1 million by 2026 “According to Polaris Market Research report, Xerostomia (Dry Mouth) Therapeutics Market is witnessing major innovations & transformations and is anticipated to reach USD 822.1 million by 2026, registering a CAGR of 3.6% during the forecast period 2019 to 2026. The global Xerostomia (Dry Mouth) Therapeutics Market report sheds light on the key dynamics of the global market, analyzing the data on a historical basis and forecasted data till the year 2026 The market analysis covered in the report includes data in terms of value $822.1 Million.The market overview section of the report covers the global industry overview, microeconomic and macroeconomic outlook, and forecasted factors. The market dynamics section of this report includes major drivers, restraints, trends, and opportunities emerging in the market. Xerostomia (Dry Mouth) Therapeutics Market Report Scope: The global Xerostomia (Dry Mouth) Therapeutics Market is segmented based on Product, Distribution Channel and geographic region. The motive of the research report is to define market dynamics of different countries & segments in the recent time and to forecast the values for the coming years. The report is specifically designed to incorporate quantitative and qualitative aspects of the market within each country and region involved in the study. The report caters the extensive information regarding the driving factors & hurdles that will define the future outlook for the market. Additionally, the report also incorporates prevailing and emerging opportunities for stakeholders to invest along with the in-depth detailed analysis of product/services offerings of prominent players shaping the overall development of the market. - 2 -

  3. Xerostomia (Dry Mouth) Therapeutics Market Size Worth USD 822.1 million by 2026 Product Outlook Distribution Channel By Region Type Outlook • • • Artificial Saliva Hospital Pharmacies North America (U.S., Canada) • • • Dentifrices Retail Pharmacies Europe (France, Germany, UK, Italy, Spain, • • Netherlands, Austria) Salivary Stimulants Online Pharmacies • • Asia Pacific (Japan, China, India, Malaysia, Indonesia, Saliva Substitutes • South Korea) Drugs • • Latin America (Brazil, Mexico, Argentina) Salivary Pen • Middle East & Africa (Saudi Arabia, UAE, Israel, South Africa) COVID-19 Impact Analysis for Xerostomia (Dry Mouth) Therapeutics Market COVID-19 is an ongoing public health emergency that has impacted almost all industries globally, and its long- term effects are expected to influence the target industry growth over the forecast period. Our ongoing research features the COVID-19 impact analysis section as a key part of the report to uncover the major issues and potential paths forward. In this report, the insights provided in terms of changes in consumer behavior and purchasing patterns, dynamics of current market forces, re-routing of the supply chain, and the interventions of governments. The latest study incorporates analysis, estimations, insights, and forecasts, considering the COVID-19 impact on the market. Gain access to our latest research report that includes in-depth analysis of the COVID-19 pandemic impacting the the Xerostomia (Dry Mouth) Therapeutics Market in different regions and how leading players are forming strategies to mitigate the adverse effect of the pandemic and take benefit of emerging opportunities : Browse Detailed Research Report On Xerostomia (Dry Mouth) Therapeutics Market Analysis: https://www.polarismarketresearch.com/industry-analysis/xerostomia-therapeutics-market Regional Outlook Among regional markets, the region emerged as the promising regional market with its higher revenue share contribution. The growth in this regional market is primarily attributed to the ongoing technological - 3 -

  4. Xerostomia (Dry Mouth) Therapeutics Market Size Worth USD 822.1 million by 2026 advancements in the industry, increasing economic stability, huge government investments, and growing awareness related to the benefits of the product/service. Competitive Landscape The report offers a complete industry analysis while featuring the competitive landscape that includes company financials, product portfolios, major breakthroughs, and upcoming projects. The report includes a detailed view of the global market, along with changing scenarios, trends, regional segmentation, regional landscape, major investments, and details of historical, present, and projected revenues. According to Polaris Market Research, the key players with a noteworthy dominance in the Xerostomia (Dry Mouth) Therapeutics Market include Colgate-Palmolive Company, Church & Dwight Co., Inc, EUSA Pharma, GlaxoSmithKline plc, Forward Science, Mission Pharmacal Company, Eisai Inc., OraHealth Inc., Parnell Pharmaceuticals, Inc., OraPharma, Inc, Saliwell Ltd., Dentaid, and Sun Pharmaceutical Industries Limited. Request for sample: https://www.polarismarketresearch.com/industry-analysis/xerostomia- therapeutics-market/request-for-sample Table of Contents 1.Overview and Scope 1.1.Research goal & scope 1.2.Research assumptions 1.3.Research Methodology 1.3.1.Primary data sources 1.3.2.Secondary data sources 1.4.Key take-aways 1.5.Stakeholders 2.Executive Summary 2.1.Market Definition 2.2.Market Segmentation 3.Xerostomia Therapeutics Market Insights 3.1.Xerostomia Therapeutics – Industry snapshot 3.2.Xerostomia Therapeutics - Ecosystem analysis 3.3.Xerostomia Therapeutics Market dynamics 3.3.1.Xerostomia Therapeutics – Market Forces 3.3.1.1. Xerostomia Therapeutics Market driver analysis 3.3.1.2. Xerostomia Therapeutics Market restraint/challenges analysis 3.3.1.3. Xerostomia Therapeutics Market opportunity analysis 3.4.Industry analysis - Porter's five force 3.4.1.Bargaining power of supplier 3.4.2.Bargaining power of buyer 3.4.3.Threat of substitute 3.4.4.Threat of new entrant 3.4.5.Degree of competition 3.5.Xerostomia Therapeutics Market PEST analysis, 2017 - 4 -

  5. Xerostomia (Dry Mouth) Therapeutics Market Size Worth USD 822.1 million by 2026 3.6.Xerostomia Therapeutics Industry trends 3.7.Competitive Ranking Analysis 4.Xerostomia Therapeutics Market Size and Forecast by Products 4.1.Key findings 4.2.Artificial Saliva 4.2.1.Global market estimates and forecasts, 2017 – 2026 4.3.Dentifrices 4.3.1.Global market estimates and forecasts, 2017 – 2026 4.4.Salivary Stimulants 4.4.1.Global market estimates and forecasts, 2017 – 2026 4.5.Saliva Substitutes 4.5.1.Global market estimates and forecasts, 2017 – 2026 4.6.Drugs 4.6.1.Global market estimates and forecasts, 2017 – 2026 4.7.Salivary Pen 4.7.1.Global market estimates and forecasts, 2017 – 2026 5.Xerostomia Therapeutics Market Size and Forecast by Distribution Channel 5.1.Key findings 5.2.Hospital Pharmacies 5.2.1.Global market estimates and forecasts, 2017 - 2026 5.3.Retail Pharmacies 5.3.1.Global market estimates and forecasts, 2017 – 2026 5.4.Online Pharmacies 5.4.1.Global market estimates and forecasts, 2017 – 2026 6.Xerostomia Therapeutics Market Size and Forecast by Regions 6.1.Key findings 6.2.North America 6.2.1.Xerostomia Therapeutics Market by Products, 2017 - 2026 6.2.2.Xerostomia Therapeutics Market by Distribution Channel, 2017 - 2026 6.2.3.U.S. 6.2.3.1. Xerostomia Therapeutics Market by Products, 2017 - 2026 6.2.3.2. Xerostomia Therapeutics Market by Distribution Channel, 2017 - 2026 6.2.4.Canada 6.2.4.1. Xerostomia Therapeutics Market by Products, 2017 - 2026 6.2.4.2. Xerostomia Therapeutics Market by Distribution Channel, 2017 - 2026 6.3.Europe 6.3.1.Xerostomia Therapeutics Market by Products, 2017 - 2026 6.3.2.Xerostomia Therapeutics Market by Distribution Channel, 2017 - 2026 6.3.3.Germany 6.3.3.1. Xerostomia Therapeutics Market by Products, 2017 - 2026 6.3.3.2. Xerostomia Therapeutics Market by Distribution Channel, 2017 - 2026 6.3.4.UK 6.3.4.1. Xerostomia Therapeutics Market by Products, 2017 - 2026 6.3.4.2. Xerostomia Therapeutics Market by Distribution Channel, 2017 - 2026 6.3.5.France 6.3.5.1. Xerostomia Therapeutics Market by Products, 2017 - 2026 6.3.5.2. Xerostomia Therapeutics Market by Distribution Channel, 2017 - 2026 6.3.6.Italy 6.3.6.1. Xerostomia Therapeutics Market by Products, 2017 - 2026 6.3.6.2. Xerostomia Therapeutics Market by Distribution Channel, 2017 - 2026 6.4.Asia Pacific - 5 -

  6. Xerostomia (Dry Mouth) Therapeutics Market Size Worth USD 822.1 million by 2026 6.4.1.Xerostomia Therapeutics Market by Products, 2017 - 2026 6.4.2.Xerostomia Therapeutics Market by Distribution Channel, 2017 - 2026 6.4.3.China 6.4.3.1. Xerostomia Therapeutics Market by Products, 2017 - 2026 6.4.3.2. Xerostomia Therapeutics Market by Distribution Channel, 2017 - 2026 6.4.4.India 6.4.4.1. Xerostomia Therapeutics Market by Products, 2017 - 2026 6.4.4.2. Xerostomia Therapeutics Market by Distribution Channel, 2017 - 2026 6.4.5.Japan 6.4.5.1. Xerostomia Therapeutics Market by Products, 2017 - 2026 6.4.5.2. Xerostomia Therapeutics Market by Distribution Channel, 2017 - 2026 6.4.6.Australia 6.4.6.1. Xerostomia Therapeutics Market by Products, 2017 - 2026 6.4.6.2. Xerostomia Therapeutics Market by Distribution Channel, 2017 - 2026 6.5.Latin America 6.5.1.Xerostomia Therapeutics Market by Products, 2017 - 2026 6.5.2.Xerostomia Therapeutics Market by Distribution Channel, 2017 - 2026 6.5.3.Brazil 6.5.3.1. Xerostomia Therapeutics Market by Products, 2017 - 2026 6.5.3.2. Xerostomia Therapeutics Market by Distribution Channel, 2017 - 2026 6.5.4.Mexico 6.5.4.1. Xerostomia Therapeutics Market by Products, 2017 - 2026 6.5.4.2. Xerostomia Therapeutics Market by Distribution Channel, 2017 - 2026 6.6.Middle East & Africa 6.6.1.Xerostomia Therapeutics Market by Products, 2017 - 2026 6.6.2.Xerostomia Therapeutics Market by Distribution Channel, 2017 - 2026 7.Company Profiles 7.1.Eisai Inc. 7.1.1.Overview 7.1.2.Financials 7.1.3.Product Benchmarking 7.1.4.Recent Developments 7.2.Colgate-Palmolive Company 7.2.1.Overview 7.2.2.Financials 7.2.3.Product Benchmarking 7.2.4.Recent Developments 7.3.Dentaid 7.3.1.Overview 7.3.2.Financials 7.3.3.Product Benchmarking 7.3.4.Recent Developments 7.4.EUSA Pharma 7.4.1.Overview 7.4.2.Financials 7.4.3.Product Benchmarking 7.4.4.Recent Developments 7.5.Forward Science 7.5.1.Overview 7.5.2.Financials 7.5.3.Product Benchmarking - 6 -

  7. Xerostomia (Dry Mouth) Therapeutics Market Size Worth USD 822.1 million by 2026 7.5.4.Recent Developments 7.6.GlaxoSmithKline plc 7.6.1.Overview 7.6.2.Financials 7.6.3.Product Benchmarking 7.6.4.Recent Developments 7.7.Mission Pharmacal Company 7.7.1.Overview 7.7.2.Financials 7.7.3.Product Benchmarking 7.8.OraHealth Inc. 7.8.1.Overview 7.8.2.Financials 7.8.3.Product Benchmarking 7.8.4.Recent Developments 7.9.OraPharma, Inc. 7.9.1.Overview 7.9.2.Financials 7.9.3.Product Benchmarking 7.9.4.Recent Developments 7.10. Parnell Pharmaceuticals, Inc. 7.10.1.Overview 7.10.2.Financials 7.10.3.Product Benchmarking 7.10.4.Recent Developments Access Press Release on Xerostomia (Dry Mouth) Therapeutics Market: https://www.polarismarketresearch.com/press-releases/global-xerostomia-therapeutics-market About Polaris Market Research Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for our clientele spread across different enterprises. We at Polaris are obliged to serve our diverse customer base present across the industries of healthcare, technology, semi-conductors, and chemicals among various other industries present around the world. We strive to provide our customers with updated information on innovative technologies, high growth markets, emerging business environments, and the latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced, and extremely qualified team of experts comprising SMEs, analysts, and consultants, we at Polaris endeavor to deliver value-added business solutions to our customers. E mail Id: sales@polarismarketresearch.com Web: www.polarismarketresearch.com Official Blog: http://polarismarketresearch.blogspot.com - 7 -

More Related